Viewing Study NCT03945903


Ignite Creation Date: 2025-12-24 @ 7:19 PM
Ignite Modification Date: 2026-02-18 @ 3:48 AM
Study NCT ID: NCT03945903
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2023-04-13
First Post: 2019-04-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pre-Approval Access to Golimumab Subcutaneous for the Treatment of Stage 3 Type-1 Diabetes Mellitus in Children and Young Adults
Sponsor: Janssen Research & Development, LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module